Cargando…

Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device

Nasal high flow is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. The administration of a high flow of heated and humidified gas mixture promotes higher and more stable inspiratory oxygen fraction values, decreases...

Descripción completa

Detalles Bibliográficos
Autores principales: Ischaki, Eleni, Pantazopoulos, Ioannis, Zakynthinos, Spyros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488954/
https://www.ncbi.nlm.nih.gov/pubmed/28794144
http://dx.doi.org/10.1183/16000617.0028-2017
_version_ 1784792776438710272
author Ischaki, Eleni
Pantazopoulos, Ioannis
Zakynthinos, Spyros
author_facet Ischaki, Eleni
Pantazopoulos, Ioannis
Zakynthinos, Spyros
author_sort Ischaki, Eleni
collection PubMed
description Nasal high flow is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. The administration of a high flow of heated and humidified gas mixture promotes higher and more stable inspiratory oxygen fraction values, decreases anatomical dead space and generates a positive airway pressure that can reduce the work of breathing and enhance patient comfort and tolerance. Nasal high flow has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxaemic respiratory failure, with the majority of studies showing positive results. Recently, its clinical indications have been expanded to post-extubated patients in intensive care or following surgery, for pre- and peri-oxygenation during intubation, during bronchoscopy, in immunocompromised patients and in patients with “do not intubate” status. In the present review, we differentiate studies that suggest an advantage (benefit) from other studies that do not suggest an advantage (no benefit) compared to conventional oxygen devices or noninvasive ventilation, and propose an algorithm in cases of nasal high flow application in patients with acute hypoxaemic respiratory failure of almost any cause.
format Online
Article
Text
id pubmed-9488954
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94889542022-11-14 Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device Ischaki, Eleni Pantazopoulos, Ioannis Zakynthinos, Spyros Eur Respir Rev Reviews Nasal high flow is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. The administration of a high flow of heated and humidified gas mixture promotes higher and more stable inspiratory oxygen fraction values, decreases anatomical dead space and generates a positive airway pressure that can reduce the work of breathing and enhance patient comfort and tolerance. Nasal high flow has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxaemic respiratory failure, with the majority of studies showing positive results. Recently, its clinical indications have been expanded to post-extubated patients in intensive care or following surgery, for pre- and peri-oxygenation during intubation, during bronchoscopy, in immunocompromised patients and in patients with “do not intubate” status. In the present review, we differentiate studies that suggest an advantage (benefit) from other studies that do not suggest an advantage (no benefit) compared to conventional oxygen devices or noninvasive ventilation, and propose an algorithm in cases of nasal high flow application in patients with acute hypoxaemic respiratory failure of almost any cause. European Respiratory Society 2017-09-08 /pmc/articles/PMC9488954/ /pubmed/28794144 http://dx.doi.org/10.1183/16000617.0028-2017 Text en Copyright ©ERS 2017. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Ischaki, Eleni
Pantazopoulos, Ioannis
Zakynthinos, Spyros
Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title_full Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title_fullStr Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title_full_unstemmed Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title_short Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
title_sort nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488954/
https://www.ncbi.nlm.nih.gov/pubmed/28794144
http://dx.doi.org/10.1183/16000617.0028-2017
work_keys_str_mv AT ischakieleni nasalhighflowtherapyanoveltreatmentratherthanamoreexpensiveoxygendevice
AT pantazopoulosioannis nasalhighflowtherapyanoveltreatmentratherthanamoreexpensiveoxygendevice
AT zakynthinosspyros nasalhighflowtherapyanoveltreatmentratherthanamoreexpensiveoxygendevice